Showing results (41-50 of 65) with videos related to
Sort By:
Pageof 7
Pulmonary Circulation|March 4, 2026
The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of LifeKatherine Bunclark, Joseph Newman, Hakim Ghani, et al.Pulmonary Circulation|March 4, 2026
The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3Katherine Bunclark, Joseph Newman, Hakim Ghani, et al.Nature Microbiology|July 14, 2022
Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2Joseph Newman, Nazia Thakur, Thomas P Peacock, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|May 14, 2025
Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life frameworkFrances Varian, Rebecca Burney, Charlotte Pearson, et al.ERJ Open Research|December 24, 2025
The Pulmonary Hypertension Global Patient Survey: understanding the experiences and perspectives of patientsJoseph Newman, Hakim Ghani, Shiv Munagala, et al.Pulmonary Circulation|March 4, 2026
The Pulmonary Hypertension Global Patient Survey: Understanding the Invisible Burden of Paediatric Pulmonary HypertensionSadia Quyam, Sarah Drumm, Shiv Mungala, et al.The Lancet. Respiratory Medicine|May 22, 2023
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitationSally J Singh, Molly M Baldwin, Enya Daynes, et al.Journal of Medicinal Chemistry|October 18, 2011
Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II: broad-spectrum antibacterial agents with reduced hERG activityFolkert Reck, Richard Alm, Patrick Brassil, et al.Plos One|August 17, 2018
Generation and characterisation of recombinant FMDV antibodies: Applications for advancing diagnostic and laboratory assaysGareth Shimmon, Abhay Kotecha, Jingshan Ren, et al.Research Square|February 23, 2022
Efficacy of ChAdOx1 vaccines against SARS-CoV-2 Variants of Concern Beta, Delta and Omicron in the Syrian hamster modelNeeltje van Doremalen, Jonathan E Schulz, Danielle R Adney, et al.Pageof 7